skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

Neuropsychiatric Disease and Treatment

(2,361,227) Views

Editor in Chief Dr Roger M Pinder

1176-6328

Case report
Very early onset and greater vulnerability in schizophrenia: A clinical and neuroimaging study
Francesco Margari, Anna Presicci, Maria Giuseppina Petruzzelli, Patrizia Ventura, Franca Di Cuonzo, et al
Neuropsychiatric Disease and Treatment 2008, 4:825-830
09 September 2008

Review
Estrogen receptor-mediated neuroprotection: The role of the Alzheimer’s disease-related gene seladin-1
Alessandro Peri, Mario Serio
Neuropsychiatric Disease and Treatment 2008, 4:817-824
09 September 2008

Review
Psychiatric disorders and traumatic brain injury
Marcelo Schwarzbold, Alexandre Diaz, Evandro Tostes Martins, Armanda Rufino, Lúcia Nazareth Amante, et al
Neuropsychiatric Disease and Treatment 2008, 4:797-816
09 September 2008

Review
Pharmacotherapy of panic disorder
Charles B Pull, Cristian Damsa
Neuropsychiatric Disease and Treatment 2008, 4:779-795
09 September 2008

Review
Present and prospective clinical therapeutic regimens for Alzheimer’s disease
Mustafa M Husain, Kenneth Trevino, Haroon Siddique, Shawn M McClintock
Neuropsychiatric Disease and Treatment 2008, 4:765-777
09 September 2008

Review
Anxiolytics may promote locomotor function recovery in spinal cord injury patients
Pierre A Guertin
Neuropsychiatric Disease and Treatment 2008, 4:759-763
09 September 2008

Review
Current approaches to the treatment of Parkinson’s disease
Joseph Jankovic, L Giselle Aguilar
Neuropsychiatric Disease and Treatment 2008, 4:743-757
08 September 2008

Review
Diffusion tensor imaging investigations in Alzheimer’s disease: the resurgence of white matter compromise in the cortical dysfunction of the aging brain
David A Medina, Moises Gaviria
Neuropsychiatric Disease and Treatment 2008, 4:737-742
08 September 2008

Expert Opinion
Tiagabine: efficacy and safety in partial seizures – current status
Jürgen Bauer, Déirdre Cooper-Mahkorn
Neuropsychiatric Disease and Treatment 2008, 4:731-736
08 September 2008

Review
Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
Roberto Canitano, Valeria Scandurra
Neuropsychiatric Disease and Treatment 2008, 4:723-730
08 September 2008

Original Research
Cognitive impairment and Alzheimer’s disease: Links with oxidative stress and cholesterol metabolism
Alejandra Sekler, José M Jiménez, Leonel Rojo, Edgard Pastene, Patricio Fuentes, et al
Neuropsychiatric Disease and Treatment 2008, 4:715-722
01 January 1970

Original Research
Parkinson’s disease and the frequent reasons for emergency admission
Ozlem Guneysel, Oguzhan Onultan, Ozge Onur
Neuropsychiatric Disease and Treatment 2008, 4:711-714
08 September 2008

Original Research
Beneficial effect of pramipexole for motor function and depression in Parkinson’s disease
Osamu Kano, Ken Ikeda, Tetsuhito Kiyozuka, Konosuke Iwamoto, Hirono Ito, et al
Neuropsychiatric Disease and Treatment 2008, 4:707-710
16 February 2009

Original Research
A preliminary report of the dopamine receptor D4 and the dopamine transporter 1 gene polymorphism and its association with attention deficit hyperactivity disorder
Helmut Niederhofer, Frauke Menzel, Karl Göbel, Brigitte Hackenberg, Rainer Richter, et al
Neuropsychiatric Disease and Treatment 2008, 4:701-705
08 September 2008

Original Research
The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na+, K+)-, Mg2+-ATPase activities, antioxidant status, and learning performance of aged rats
Haris Carageorgiou, Antonios C Sideris, Ioanna Messari, Chrissoula I Liakou, Stylianos Tsakiris
Neuropsychiatric Disease and Treatment 2008, 4:687-699
08 September 2008